Latest Transformation Programs News

Wesfarmers has reported a 9.3% rise in net profit after tax to $1.6 billion for H1 2026, driven by robust performances in Bunnings, Kmart Group, and lithium operations. The company also announced a 7.4% increase in its interim dividend amid ongoing cost pressures and strategic AI partnerships.

Healius Limited reported solid half-year results for 1H26, with revenue growth driven by pathology and Agilex Biolabs, alongside significant progress in digital transformation and AI integration.

Treasury Wine Estates reported a statutory loss driven by a significant US asset impairment but showed underlying growth in key markets. The company suspends its interim dividend and targets $100 million in annual cost savings through its TWE Ascent program.

Treasury Wine Estates reports a sharp 39.6% drop in earnings and a $649 million statutory loss due to a major US asset impairment, suspending dividends to preserve capital while advancing a $100 million cost-cutting transformation.

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.

Westpac Banking Corporation reported a 6% rise in net profit for the first quarter of 2026, underpinned by strong capital ratios and ongoing transformation initiatives. The bank’s strategic focus on customer service and operational efficiency signals a confident outlook amid evolving market conditions.

AGL Energy reported a steady first half with flat underlying EBITDA and a narrowed FY26 earnings outlook, while accelerating its renewable projects and forming a strategic partnership with Aussie Broadband.

CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.

CSL Limited reported a 7% decline in underlying NPATA to US$1.9 billion for the half-year, weighed down by restructuring costs and impairments, yet maintains full-year guidance and expands its share buy-back program.

CSL Limited reported a sharp 80% drop in net profit for the half year ended December 2025, driven by significant restructuring and impairment charges, yet maintained its growth guidance and dividend payout.

Amotiv Limited reported a solid FY26 half-year result with revenue growth and margin pressures partly offset by its Amotiv Unified transformation program. The company maintained its FY26 guidance, highlighting strong cash flow and shareholder returns.